- Home
- MDGL vs MTN Comparison
MDGL vs MTN Comparison
Compare MDGL & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- MTN
- Stock Information
- Founded
- MDGL 2011
- MTN 1997
- Country
- MDGL United States
- MTN United States
- Employees
- MDGL N/A
- MTN N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- MTN Services-Misc. Amusement & Recreation
- Sector
- MDGL Health Care
- MTN Consumer Discretionary
- Exchange
- MDGL Nasdaq
- MTN Nasdaq
- Market Cap
- MDGL 7.5B
- MTN 7.1B
- IPO Year
- MDGL N/A
- MTN 1997
- Fundamental
- Price
- MDGL $323.98
- MTN $157.91
- Analyst Decision
- MDGL Buy
- MTN Hold
- Analyst Count
- MDGL 10
- MTN 9
- Target Price
- MDGL $354.75
- MTN $193.33
- AVG Volume (30 Days)
- MDGL 317.3K
- MTN 639.9K
- Earning Date
- MDGL 05-06-2025
- MTN 03-10-2025
- Dividend Yield
- MDGL N/A
- MTN 5.62%
- EPS Growth
- MDGL N/A
- MTN 10.73
- EPS
- MDGL N/A
- MTN 6.89
- Revenue
- MDGL $180,133,000.00
- MTN $2,946,168,000.00
- Revenue This Year
- MDGL $228.41
- MTN $5.54
- Revenue Next Year
- MDGL $73.44
- MTN $4.20
- P/E Ratio
- MDGL N/A
- MTN $22.92
- Revenue Growth
- MDGL N/A
- MTN 3.57
- 52 Week Low
- MDGL $189.00
- MTN $151.99
- 52 Week High
- MDGL $377.46
- MTN $233.57
- Technical
- Relative Strength Index (RSI)
- MDGL 45.41
- MTN 43.73
- Support Level
- MDGL $310.00
- MTN $158.64
- Resistance Level
- MDGL $350.50
- MTN $164.71
- Average True Range (ATR)
- MDGL 13.02
- MTN 3.69
- MACD
- MDGL -1.72
- MTN 0.14
- Stochastic Oscillator
- MDGL 34.52
- MTN 24.72
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About MTN Vail Resorts Inc.
Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.